The Effects of Pregabalin on Gastric Ulcer Formation and Antioxidant Parameters
Öz
Pregabalin, a drug used in epilepsy, anxiety, neuropathic pain is reported to have analgesic effects in inflammatory pain. We aimed to investigate whether pregabalin have gastric side effects and to compare with a non steroidal antiinflammatory drug (NSAID) in rats. The effects of pregabalin on antioxidant levels, which are suggested to protect against gastric mucosal damage were also studied. Pregabalin 30, 50, 100 mg/kg, indomethacin 5 mg/kg (reference-NSAID), saline (control group) were administered orally for 10 days. At the end of 10 day treatment, rats were sacrificed, gastric tissues were removed out, mucus secretion was determined spectrophotometrically, ulcer index was scored from score 0:(no-petechia) to score 3:(petechia>5mm). Also, to evaluate the antioxidant effects of pregabalin, malondialdehyde (MDA) levels, catalase and superoxide dismutase (SOD) activities in gastric tissue were studied. Pregabalin 50 mg/kg and 100 mg/kg similar to indomethacin significantly reduced mucus secretion and increased ulcer index compared to control while pregabalin 30 mg/kg did not. Pregabalin 30 mg/kg and 100 mg/kg decreased SOD and catalase levels. Pregabalin 100 mg/kg dose increased MDA levels. 50 mg/kg and 100 mg/kg pregabalin showed gastric side effects as reduced mucus secretion and ulcer formation similar to indomethacin and 30 mg/kg pregabalin may be reasonable dose without showing gastric side effects. Pregabalin 50 mg/kg seems to have enhancing effects on antioxidant levels.
Anahtar Kelimeler
Kaynakça
- 1. Eutamene H, Coelho AM, Theodorou V, Toulouse M, Chovet M, Doherty A, et al. Antinociceptive effect of pregabalin in septic shock-induced rectal hypersensitivity in rats. The Journal of pharmacology and experimental therapeutics. 2000;295(1):162-7.
- 2. Ceyhan M. TE. Yeni Bir Antikonvülsan Pregabalin: Preklinik Veriler. Turk J Neurol. 2008;14(3):161-71.
- 3. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. The Cochrane database of systematic reviews. 2009(3):Cd007076.
- 4. Abou-Khalil BW. Antiepileptic Drugs. Continuum (Minneapolis, Minn). 2016;22(1 Epilepsy):132-56.
- 5. Kaygisiz B, Kilic FS, Senguleroglu N, Baydemir C, Erol K. The antinociceptive effect and mechanisms of action of pregabalin in mice. Pharmacological reports : PR. 2015;67(1):129-33.
- 6. Saritas TB, Korkmaz M, Sevimli A, Saritas ZK. Comparison of the effects of gabapentin and pregabalin on wound healing in rats. International wound journal. 2016;13(5):748-53.
- 7. Buffum M, Buffum JC. Nonsteroidal anti-inflammatory drugs in the elderly. Pain management nursing : official journal of the American Society of Pain Management Nurses. 2000;1(2):40-50.
- 8. Harirforoosh S, Asghar W, Jamali F. Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques. 2013;16(5):821-47.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yazarlar
Bilgin Kaygisiz
*
0000-0001-5910-9914
Türkiye
Sule Aydin
0000-0003-2498-8378
Türkiye
Cafer Yildirim
Bu kişi benim
0000-0002-1565-9217
Türkiye
Yayımlanma Tarihi
1 Ocak 2020
Gönderilme Tarihi
26 Ekim 2018
Kabul Tarihi
24 Aralık 2018
Yayımlandığı Sayı
Yıl 2020 Cilt: 42 Sayı: 1